and our remote work policy allows for more flexibility for our employees. Position: ClinicalResearchAssociate Work model: Full time... (40 hours/week) Work place: remote with availibility to travel to Jena (monthly) About the position The ClinicalResearch...
ClinicalResearchAssociate II or ClinicalResearchAssociate, Germany The ClinicalResearchAssociate II (CRA II...) or ClinicalResearchAssociate will monitor the progress of clinical studies at investigative sites or remotely, and ensure...
Hobson Prior is seeking a ClinicalResearchAssociate to join a prestigious pharmaceutical company in Germany. In... this role, you will be involved in planning, coordinating, and conducting clinicalresearch studies for in vitro diagnostics...
Hobson Prior is seeking a ClinicalResearchAssociate to join a prestigious pharmaceutical company in Germany. In... this role, you will be involved in planning, coordinating, and conducting clinicalresearch studies for in vitro diagnostics...
Position: Senior ClinicalResearchAssociate Location: Remote across Germany Company: Mid-sized CRO (2000+ employees... as a clinical researcher. It is common for CRAs in Europe to choose this company in favour of others that are offering higher...
Position: Senior ClinicalResearchAssociate Location: Remote across Germany Company: Mid-sized CRO (2000+ employees... as a clinical researcher. It is common for CRAs in Europe to choose this company in favour of others that are offering higher...
Position: ClinicalResearchAssociate II Location: Remote across Germany Company: Mid-sized CRO (2000... as a clinical researcher. It is common for CRAs in Europe to choose this company in favour of others that are offering higher...
research to clinical-translational applications. The researchers at the institute develop new approaches for diagnoses... a position as ResearchAssociate / Postdoc (m/f/x) (subject to personal qualification employees are remunerated...
Position: Senior ClinicalResearchAssociate Location: Remote across Germany Company: Mid-sized CRO (2000... as a clinical researcher. It is common for CRAs in Europe to choose this company in favour of others that are offering higher...
Einleitung Die ClinSol GmbH & Co. KG ist eine junge und aufstrebende Firma in den Bereichen klinische Auftragsforschung, im Rahmen nationaler & internationaler Studienprojekte, und Medical Education. Aufgaben Organisation, Koordination und ...
Six-time Olympic gold medallist Sir Chris Hoy tells BBC Breakfast about his life with terminal cancer and the legacy he hopes to leave. Continue Reading »
NMDC's board will evaluate a proposed bonus share issue and review financial results for the quarter ending September 2024 next week. The last bonus issue occurred in May 2008. Continue Reading »
ACME Solar Holdings, a leading renewable energy player in India, is set to go public with its IPO opening on November 6th. The company aims to raise ₹2,900 crore through a mix of fresh equity and offer for sale. Continue Reading »
Many of India’s biggest IPOs, including Hyundai Motor India, Paytm and Reliance Power have resulted in losses for investors. Only a few large IPOs — such as Coal India, Zomato, and HDFC Life Insurance — have generated positive returns, with their shares trading above the issue price. Continue Reading »
US Election 2024: Donald Trump's presidency would have a limited negative impact on Indian IT firms, while a potential Kamala Harris administration would largely maintain the current policies, said brokerage firm JM Financial. Continue Reading »
Stock market rebounds: Sensex jumped over 1,100 points from day’s low and Nifty 50 traded near the 24,200 level on November 5, rebounding from early morning losses. Continue Reading »
Muthoottu Mini Financiers Limited is raising up to ₹150 crore through a public issue of secured non-convertible debentures. The NCDs, priced at ₹1,000 each, are open for subscription from October 30 to November 13, 2024. Continue Reading »
Sagility IPO: Sagility India Ltd has launched its IPO with subscriptions open from November 5 to November 7, priced at ₹28-30 per share. The company has garnered over ₹945 crore from anchor investors, but initial bidding has seen slow traction despite strong retail interest. Continue Reading »